Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond

Area of Science:

• Clinical Trials
• Cardiovascular Research
• Infectious Diseases

Background:

• The COVID-19 pandemic created significant challenges for conducting clinical trials, particularly for outpatient settings.
• Thrombotic complications are a major concern in symptomatic COVID-19 patients.
• The National Heart, Lung, and Blood Institute convened a meeting to address these issues.

Purpose of the Study:

• To discuss strategies for conducting outpatient clinical trials in the COVID-19 era and beyond.
• To identify approaches for decreasing thrombotic complications in symptomatic outpatients with COVID-19.
• To address key challenges in trial design and execution.

Main Methods:

• Discussion among investigators at the National Heart, Lung, and Blood Institute.
• Focus on three primary challenges: remote trial conduct, regulatory navigation, and diverse participant recruitment.
• Exploration of innovative trial methodologies.

Main Results:

• The abstract does not contain specific results, but outlines the challenges and discussion points.
• Key areas for improvement in trial design and execution were identified.
• Strategies for overcoming logistical and ethical barriers were considered.

Conclusions:

• Adapting clinical trial methodologies is crucial for managing diseases like COVID-19.
• Remote trial conduct, regulatory flexibility, and diverse recruitment are essential for future research.
• Continued innovation is needed to ensure effective and inclusive clinical research.